Application no. and date | 99960405.1 (espacenet) (Federated) (European Patent Register), 19991116 | Patent/reg. no. and date | DK/EP 1133316, 20090121 | Publication date | 20010919 | Priority no. and date | US 108606 P, 19981116, US 133116 P, 19990507 | EP pub. no. and date |
EP 1133316 20010919 | Effective date | | Applicant/owner | Crucell Holland B.V., Archimedesweg 4
2333 CN Leiden, NL | Applicant ref. no. | 135900 | Inventor | WU, Zheng, 2930 Cotton Stock Dr.
Sugar Land, TX 77479, US, ZHANG, Shuyuan, 736 Iris Lane
Media, PA 19063, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 47/10 (2006.01) , A61K 47/42 (2006.01) , A61K 48/00 (2006.01) | Title | Adenovirus-formulering til genterapi | Int. application no. | US1999027177 | Int. publication no. | WO2000029024 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|